Ultra-long-acting (XLA) antivirals for chronic viral hepatitis

Viral hepatitis is among the top four causes of mortality globally, causing 1.4 million deaths each year, exceeding tuberculosis, malaria and human immunodeficiency virus. Hepatitis B and C are responsible for 90% of hepatitis deaths, and the remaining 10% are caused by other hepatitis viruses. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Soriano, Vicente, Alvarez, Carmen, Edagwa, Benson, de Mendoza, Carmen, Montoya, Noemí, Treviño, Ana, Gendelman, Howard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204217/
https://www.ncbi.nlm.nih.gov/pubmed/34728344
http://dx.doi.org/10.1016/j.ijid.2021.10.052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204217/
https://www.ncbi.nlm.nih.gov/pubmed/34728344
http://dx.doi.org/10.1016/j.ijid.2021.10.052

Ejemplares similares